Basic Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Mar 21, 2017; 23(11): 1980-1989
Published online Mar 21, 2017. doi: 10.3748/wjg.v23.i11.1980
Table 1 Comparison of the cagA (EPIYA motifs) and vacA s and m genotypes found before and after anti-Helicobacter pylori treatment in isolates from patients with treatment failure
Patient (n = 10)Anatomic locationAnti-H. pylori treatment
Genotype
EPIYA motifs (bp)
BeforeAfterBeforeAfter
SV314Antrum lesser curvaturecagA+/vacA s1m11cagA+/vacA s1m1495200
Antrum greater curvaturecagA+/vacA s1m11cagA+/vacA s1m1495/200200
SV318Antrum lesser curvaturecagA+/vacA s1m11cagA+/vacA s1m1495595/495
Antrum greater curvaturecagA+/vacA s1m11No change200595/495
Body greater curvaturecagA+/vacA s1m11CagA+/vacA s1m1495/200NA
SV377Antrum lesser curvaturecagA+/vacA s2m22cagA+/vacA s1m1695/595/495/200200
Antrum greater curvaturecagA+/vacA s2m22cagA+/vacA s1m1NA200
Body greater curvaturecagA+/vacA s2m22Undefined200495
SV415Antrum lesser curvaturecagA+/vacA s1m11cagA+/vacA s1m1495495/200
Body greater curvaturecagA+/vacA s1m11cagA+/vacA s1m1495/200495
SV444Body greater curvaturecagA+/vacA s1m1No change595595
SV471Antrum greater curvaturecagA+/vacA s1m11cagA+/vacA s1m1495595
Body greater curvaturecagA+/vacA s1m11cagA+/vacA s1m1495/200595
SV480Antrum lesser curvaturecagA+/vacA s2m22cagA+/vacA s1m11595/495595/200
Body greater curvaturecagA+/vacA s2m22cagA+/vacA s1/m1200595
SV509Antrum lesser curvaturecagA+/vacA s1m11cagA+/vacA s1m1200NA
Antrum greater curvaturecagA+/vacA s1m11cagA+/vacA s1m1200495
SV512Antrum greater curvaturecagA+/vacA s1m11cagA+/ vacAs1m1495NA
Body greater curvaturecagA+/vacA s1m11No change495/200595
SV526Antrum lesser curvaturecagA+/vacA s1m1cagA+/vacA s1m11595NA
Antrum greater curvaturecagA+/vacA s1m11cagA+/vacA s1m1595/200595
Body greater curvaturecagA+/vacA s1m11cagA+/vacA s1m1595/200595
Table 2 Effect of the antibiotic pressure on the virulence-associated genotypes of Helicobacter pylori isolates obtained from 10 Colombian patients with treatment failure
GenotypeBefore treatment (n = 22)After treatment (n = 22)P vaule
cagA
Positive2 (9.1)17 (77.3)0.000
Mixed20 (90.9)5 (22.7)
vacA
s1m117 (22.7)21 (95.5)0.125
s2m25 (77.3)1 (4.5)